ChiCTR2500115822 版本V1.0 版本创建时间2025/12/31 14:53:06 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500115822 

最近更新日期:

Date of Last Refreshed on:

2025-12-31 14:52:59 

注册时间:

Date of Registration:

2025-12-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

MOFs衍生金属氧化物基气体传感器在肺癌快速筛查 中的应用

Public title:

Application of MOF-Derived Metal Oxide-Based Gas Sensors in Rapid Screening for Lung Cancer

注册题目简写:

English Acronym:

研究课题的正式科学名称:

MOFs衍生金属氧化物基气体传感器在肺癌快速筛查中的应用

Scientific title:

Application of MOF-Derived Metal Oxide-Based Gas Sensors in Rapid Screening for Lung Cancer

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘冬 

研究负责人:

路平 

Applicant:

Dong Liu 

Study leader:

Ping Lu 

申请注册联系人电话:

Applicant telephone:

+86 373 3831063

研究负责人电话:

Study leader's
telephone:

+86 373 4402543

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liudong081@163.com

研究负责人电子邮件:

Study leader's E-mail:

lupingdoctor@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省新乡市金穗大道601号

研究负责人通讯地址:

河南省卫辉市健康路88号

Applicant address:

No. 601, Jinsui Avenue, Xinxiang City, Henan Province

Study leader's address:

No. 88, Jiankang Road, Weihui City, Henan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

新乡医学院

Applicant's institution:

XInxiang Medical University

研究负责人所在单位:

新乡医学院第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Xinxiang Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2025]伦科快审字(94)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院第一附属医院科研伦理审查小组

Name of the ethic committee:

The Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-01 00:00:00

伦理委员会联系人:

赵嘉林

Contact Name of the ethic committee:

Jialin Zhao

伦理委员会联系地址:

河南省卫辉市健康路88号

Contact Address of the ethic committee:

No. 88, Jiankang Road, Weihui City, Henan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 373 4402079

伦理委员会联系人邮箱:

Contact email of the ethic committee:

460169003@qq.com

研究实施负责(组长)单位:

新乡医学院第一附属医院

Primary sponsor:

The First Affiliated Hospital of Xinxiang Medical University

研究实施负责(组长)单位地址:

河南省卫辉市健康路88号

Primary sponsor's address:

No. 88, Jiankang Road, Weihui City, Henan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南省

市(区县):

Country:

China

Province:

Henan

City:

单位(医院):

新乡医学院第一附属医院

具体地址:

河南省卫辉市健康路88号

Institution
hospital:

The First Affiliated Hospital of Xinxiang Medical University

Address:

No. 88, Jiankang Road, Weihui City, Henan Province

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-Selected Research Project (Self-Funded)

研究疾病:

肺癌病人筛查  

Target disease:

Diagnosis of lung cancer patients

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

验证MOFs衍生金属氧化物气体传感器对肺癌患者呼出气中正丙醇的检测能力,包括检测限、响应时间、恢复时间及稳定性。评估该传感器在临床环境中区分肺癌患者与健康人群的诊断灵敏度与特异性;分析传感器响应信号与肺癌临床分期的相关性。  

Objectives of Study:

Validate the capability of the MOF-derived metal oxide gas sensor in detecting n-propanol in the exhaled breath of lung cancer patients, including the limit of detection, response time, recovery time, and stability. Evaluate the diagnostic sensitivity and specificity of the sensor in distinguishing lung cancer patients from healthy individuals in a clinical setting; analyze the correlation between the sensor response signals and the clinical stages of lung cancer.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.肺癌组:经病理学确诊为Ⅰ期至IV期的肺癌患者;年龄18-70岁(包含界限值,包含男性女性);意识清楚,能配合完成呼气采样;自愿参加并签署知情同意书。 2.健康对照组:无任何恶性肿瘤病史;无能配合完成呼气采样;年龄(+/-3岁)、性别与肺癌组进行匹配;自愿参加并签署书面知情同意书。

Inclusion criteria

1.Lung cancer group: Patients diagnosed with stage I to stage IV lung cancer by pathology; Age: 18-70 years old (including the threshold value, including both male and female); Clear consciousness and able to cooperate in completing breath sampling. Participate voluntarily and sign the informed consent form. 2. Healthy control group: No history of any malignant tumors; Unable to cooperate in completing the breath sampling; The age (+/-3 years) and gender were matched with the lung cancer group. Participate voluntarily and sign a written informed consent form.

排除标准:

1.近期(4周内)接受过化疗、放疗或肺部手术; 2.患有严重影响呼吸配合的神经肌肉疾病; 3.妊娠或哺乳期妇女; 4.研究者判断不适合参与本研究的其他情况。

Exclusion criteria:

1.Have received chemotherapy, radiotherapy or lung surgery in the recent period (within 4 weeks); 2. Suffering from neuromuscular diseases that seriously affect respiratory coordination; 3. Pregnant or lactating women; 4. Other circumstances where the researcher deems it unsuitable to participate in this study.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00

干预措施:

Interventions:

组别:

肺癌患者组

样本量:

36

Group:

Lung cancer patient group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

健康对照组

样本量:

36

Group:

Healthy control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南省 

市(区县):

 

Country:

China

Province:

Henan

City:

单位(医院):

新乡医学院第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Xinxiang Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

正丙醇浓度

指标类型:

主要指标

Outcome:

N-propanol concentration

Type:

Primary indicator

测量时间点:

取样后6小时内测量

测量方法:

使用一次性气体采集袋,在安静状态下采集潮气末呼出气体约2000 mL。采样后6小时内将气体样本送入实验室,由专职研究人员使用MOFs传感器进行检测。

Measure time point of outcome:

Measurement within 6 hours after sampling

Measure method:

Using a disposable gas collection bag, approximately 2000 mL of end-tidal exhaled gas was collected under quiet conditions. The gas sample was delivered to the laboratory within 6 hours of sampling, where it was analyzed by dedicated researchers using MOF (Multi-Organic Floaters) sensors

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

检测结果及临床资料录入电子病例报告表(eCRF)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Test results and clinical data are entered into the electronic Case Report Form (eCRF).

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-12-31 14:52:59